Global Botulinum Toxin Market 2017-2021 - Product Image

Global Botulinum Toxin Market 2017-2021

  • ID: 4199019
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 6

FEATURED COMPANIES

  • Acorda Therapeutics
  • Biolab Sanus Farmaceutica
  • Evolus
  • INSYS THERAPEUTICS
  • LEO Pharma
  • Pfizer
  • MORE
Botulinum toxin is a chemical substance, which is used as a drug to regulate the release of acetylcholine, the chemical that regulates the neuron flow in the nervous system to activate the muscles. To be used as a drug, botulinum toxin must be isolated, purified, and stabilized. This substance finds its place largely as one of the most sought-after muscle relaxants in the modern pharma industry for multiple indications such as cosmetic surgery, skeletal muscle relaxants, and neuromuscular relaxants to name a few.

The analysts forecast the global botulinum toxin market to grow at a CAGR of 8.16% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global botulinum toxin market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Botulinum Toxin Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- ALLERGAN
- Galderma
- Ipsen
- Merz Pharma
- Pfizer

Other prominent vendors
- Acorda Therapeutics
- Aldeyra Therapeutics
- Azidus Brasil
- Biolab Sanus Farmaceutica
- Canbex Therapeutics
- DAEWOONG
- Emcure Pharmaceuticals
- Endo Pharmaceuticals International
- Evolus
- Fresenius Kabi
- GlaxoSmithKline
- INSYS THERAPEUTICS
- Johnson & Johnson
- Lannett
- Lanzhou Institute of Biological Products
- LEO Pharma
- Mylan
- Par Pharmaceuticals
- PhytoTech Therapeutics
- Revance Therapeutics
- Sun Pharmaceuticals
- Takeda Pharmaceutical
- UroGen Pharma

Market drivers
- Rising demand for non-invasive solutions in cosmetology.
- For a full, detailed list, view the full report

Market challenges
- Side effects associated with the use of facial aesthetic products.
- For a full, detailed list, view the full report

Market trends
- Growing demand for anti-aging treatment.
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Acorda Therapeutics
  • Biolab Sanus Farmaceutica
  • Evolus
  • INSYS THERAPEUTICS
  • LEO Pharma
  • Pfizer
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Key market highlights
PART 05: Botulinum toxin: An overview

PART 06: Pipeline landscape

PART 07: Market landscape
  • Five forces analysis
PART 08: Market segmentation by drug categories
  • Aesthetic drugs market
  • Therapeutic drugs market
PART 09: Geographical segmentation
  • Botulinum toxin market in Americas
  • Botulinum toxin market in EMEA
  • Botulinum toxin market in APAC
PART 10: Decision framework

PART 11: Drivers and challenges
  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments
PART 12: Market trends
  • Growing importance of medical aesthetics
  • Technological advancement
  • Growing demand for anti-aging treatment
PART 13: Vendor landscape
  • Competitive landscape
  • Key news
PART 14: Key vendor analysis
  • ALLERGAN
  • Galderma
  • Ipsen
  • Merz Pharma
  • Pfizer
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
List of Exhibits

Exhibit 01: Pipeline landscape
Exhibit 02: Global botulinum toxin market: Snapshot
Exhibit 03: Global botulinum toxin market 2016-2021 ($ millions)
Exhibit 04: Global botulinum toxin market: Opportunity analysis
Exhibit 05: Five forces analysis
Exhibit 06: Market segmentation by drug category 2016
Exhibit 07: Global aesthetic drugs market 2016-2021 ($ millions)
Exhibit 08: Global therapeutic drugs market 2016-2021 ($ millions)
Exhibit 09: Segmentation of global botulinum toxin market based on geography 2016 and 2021
Exhibit 10: Global botulinum toxin market revenue by geography 2016-2021 ($ millions)
Exhibit 11: Market scenario in Americas
Exhibit 12: Botulinum toxin market in Americas 2016-2021 ($ millions)
Exhibit 13: Market scenario in EMEA
Exhibit 14: Botulinum toxin market in EMEA 2016-2021 ($ millions)
Exhibit 15: Market scenario in APAC
Exhibit 16: Botulinum toxin market in APAC 2016-2021 ($ millions)
Exhibit 17: Key R&D-based growth drivers
Exhibit 18: Impact of drivers
Exhibit 19: Impact of challenges
Exhibit 20: Top five non-surgical procedures (injectable) of 2015
Exhibit 21: Competitive structure analysis of global botulinum toxin market 2016
Exhibit 22: Competitive analysis of global botulinum toxin market 2016
Exhibit 23: Global market penetration of players in botulinum toxin market 2016
Exhibit 24: ALLERGAN: Key highlights
Exhibit 25: ALLERGAN: Strength assessment
Exhibit 26: ALLERGAN: Strategy assessment
Exhibit 27: ALLERGAN: Opportunity assessment
Exhibit 28: Galderma: Key highlights
Exhibit 29: Galderma: Strength assessment
Exhibit 30: Galderma: Strategy assessment
Exhibit 31: Galderma: Opportunity assessment
Exhibit 32: Ipsen: Key highlights
Exhibit 33: Ipsen: Strength assessment
Exhibit 34: Ipsen: Strategy assessment
Exhibit 35: Ipsen: Opportunity assessment
Exhibit 36: Merz Pharma: Key highlights
Exhibit 37: Merz Pharma: Strength assessment
Exhibit 38: Merz Pharma: Strategy assessment
Exhibit 39: Merz Pharma: Opportunity assessment
Exhibit 40: Pfizer: Strength assessment
Exhibit 41: Pfizer: Strategy assessment
Exhibit 42: Pfizer: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Acorda Therapeutics
  • Biolab Sanus Farmaceutica
  • Evolus
  • INSYS THERAPEUTICS
  • LEO Pharma
  • Pfizer
  • MORE
New Report Released: - Global Botulinum Toxin Market 2017-2021

The author of the report recognizes the following companies as the key players in the global botulinum toxin market: ALLERGAN, Galderma, Ipsen, Merz Pharma, and Pfizer.

Other Prominent Vendors in the market are: Acorda Therapeutics, Aldeyra Therapeutics, Azidus Brasil, Biolab Sanus Farmaceutica, Canbex Therapeutics, DAEWOONG, Emcure Pharmaceuticals, Endo Pharmaceuticals International, Evolus, Fresenius Kabi, GlaxoSmithKline, INSYS THERAPEUTICS, Johnson & Johnson, Lannett, Lanzhou Institute of Biological Products, LEO Pharma, Mylan, Par Pharmaceuticals, PhytoTech Therapeutics, Revance Therapeutics, Sun Pharmaceuticals, Takeda Pharmaceutical, and UroGen Pharma.

Commenting on the report, an analyst from the research team said: “One trend in market is growing importance of medical aesthetics. Medical aesthetics use minimally invasive cosmetic treatments to enhance individuals' physical appearances. In 2015, there were about 21 million aesthetic procedures performed globally. The demand for minimally invasive cosmetic procedures has led to increased growth in facial rejuvenation products. Baby boomers, especially in developing countries, consider aesthetic drugs a part of their routine health treatment to maintain a natural and healthy appearance. Individuals not only want to be fit and healthy but also want to minimize the visual effects of normal aging. Individuals are now requesting quick, non-invasive procedures with minimal recovery time and lesser risk. As a result, the needle is increasingly being replaced by the scalpel.”

According to the report, one driver in market is rising demand for non-invasive solutions in cosmetology. Non-invasive procedures cause less pain and have lower incidences of complications post-surgery such as adhesions and wound dehiscence. This helps in speedy recovery. Data estimates suggest that there has been a growing interest in non-invasive aesthetic procedures in the US. In 2015, non-invasive aesthetic procedures were about 80% of the overall medical aesthetic procedures in the US. The growing acceptance toward cosmetic surgeries such as facelifts and liposuction is helping increase the overall aesthetic conscious population.

With advancements in technology and growing awareness, minimally invasive and non-invasive procedures have outnumbered the traditional forms of surgery. These minimally invasive procedures are becoming increasingly popular as they come with minimal complications. BOTOX and dermal fillers are among the most popular non-invasive aesthetic rejuvenation procedures. These non-invasive procedures provide quick and efficient treatments for crow's feet and other facial wrinkles. Dermal facial fillers such as Perlane, Juvederm, and Restylane are used to treat deep wrinkles in the face to give a more natural, youthful look compared with other surgical procedures. The increasing popularity of minimally invasive and non-invasive procedures is one of the major factors contributing to the growth of the global botulinum toxin market.

Further, the report states that one challenge in market is side effects associated with the use of facial aesthetic products. All medical procedures are associated with a certain degree of risk. In the facial aesthetics market, the various side effects associated with the use of BOTOX and dermal facial fillers are posing a challenge and hindering the growth of the market. BOTOX can affect areas near or away from the injection site and can cause loss of strength, muscle weakness, blurred vision, drooping eyelids, double vision, hoarseness, change or loss of voice, troubled breathing, and troubled swallowing. The adverse effects of dermal facial fillers are likely to appear post-surgery.

They depend on the kind of dermal filler used and the duration for which the individual gets exposed to the dermal filler. The increase in the number of side effects associated with BOTOX and dermal facial fillers is discouraging many individuals from opting for such products. Customers are shifting toward other alternative cosmetic surgeries. Needles are being increasingly replaced by lasers and radio-frequency energy treatments. They work by stimulating the production of collagen and elastin, the proteins that make the skin firm, plump, and youthful. These new non-invasive procedures are comparatively less costly than BOTOX and dermal fillers.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 6
  • ALLERGAN
  • Galderma
  • Ipsen
  • Merz Pharma
  • Pfizer
  • Acorda Therapeutics
  • Aldeyra Therapeutics
  • Azidus Brasil
  • Biolab Sanus Farmaceutica
  • Canbex Therapeutics
  • DAEWOONG
  • Emcure Pharmaceuticals
  • Endo Pharmaceuticals International
  • Evolus
  • Fresenius Kabi
  • GlaxoSmithKline
  • INSYS THERAPEUTICS
  • Johnson & Johnson
  • Lannett
  • Lanzhou Institute of Biological Products
  • LEO Pharma
  • Mylan
  • Par Pharmaceuticals
  • PhytoTech Therapeutics
  • Revance Therapeutics
  • Sun Pharmaceuticals
  • Takeda Pharmaceutical
  • UroGen Pharma
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll